ClinicalTrials.Veeva

Menu

Treatment of CFS & Fibromyalgia With Recovery Factors

P

Practitioners Alliance Network

Status

Completed

Conditions

Fibromyalgia
Chronic Fatigue Syndrome

Treatments

Dietary Supplement: Recovery Factors

Study type

Interventional

Funder types

Other

Identifiers

NCT04381793
PAN study 2019-10

Details and patient eligibility

About

The study will explore if Recovery Factors improve symptoms in fibromyalgia and chronic fatigue syndrome

Full description

Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. The treatment is a unique nutritional peptide mix derived from porcine serum

Enrollment

43 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meet ACR 2010 amended Fibromyalgia criteria or CDC CFS Criteria Overall well being score of 5 of less (on 0-10 VAS)

Exclusion criteria

Pregnant Clotting disorders

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

43 participants in 1 patient group

Assessing clinical efficacy
Experimental group
Description:
Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. The treatment is a unique nutritional peptide mix derived from porcine serum. Pre-and post FIQ-R and VA symptom score will be assessed as well as overall well-being. In a subgroup, pre-and post antibody levels will also be checked. Phase 1 will be a group of 60 subjects
Treatment:
Dietary Supplement: Recovery Factors

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems